FDA Approved: LAMIVUDINE — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for lamivudine submitted by Camber Pharmaceuticals, expanding the approved product to lamivudine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Viral Hepatitis

Drugs mentioned

• Lamivudine (lamivudine)

Snippet

SUPPL AP for LAMIVUDINE (LAMIVUDINE)